Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
AISLING CAPITAL MANAGEMENT LP | 08-08-2024 | 06-30-2024 | 15 | 231,052,564 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
BridgeBio Pharma Inc. (BBIO) | COM | 1 | $153,705,606 | 6,068,125 | 0.07 | 0.06 | 0 | 0.00 | 06-30-2024 |
Syndax Pharmaceuticals, Inc. (SNDX) | COM | 2 | $21,043,250 | 1,025,000 | 0.01 | 0.01 | 0 | 0.00 | 06-30-2024 |
Verona Pharma plc (VRNA) | SPONSORED ADS | 3 | $16,127,990 | 1,115,352 | 0.01 | 0.01 | 0 | 0.00 | 06-30-2024 |
Elevation Oncology Inc (ELEV) | COM | 4 | $7,654,257 | 2,834,910 | 0.00 | 0.00 | 0 | 0.00 | 06-30-2024 |